Beijing Tiantan Biological Products Corporation Limited provided earnings guidance for the first quarter of 2016. For the quarter, the company predicts that it will suffer a loss in its business performance, with its net loss owned by shareholders of listed company to be about RMB 0.7 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.53 CNY | -0.10% | +2.54% | +1.91% |
16/05 | Bank of China Executive Vice President Steps Down | MT |
02/05 | ICBC, CCB Name Deputy Party Secretaries | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.91% | 7.18B | |
+0.46% | 91.38B | |
-2.37% | 38.68B | |
+71.86% | 27.84B | |
-12.31% | 16.05B | |
-4.54% | 13.48B | |
-10.83% | 11.73B | |
+180.20% | 10.74B | |
-48.60% | 10.39B | |
+1.50% | 8.94B |
- Stock Market
- Equities
- 600161 Stock
- News Beijing Tiantan Biological Products Co., Ltd.
- Beijing Tiantan Biological Products Corporation Limited Provides Earnings Guidance for the First Quarter of 2016